Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Patient's Morphological Characteristics on Pharmacokinetic and Toxicity of Trastuzumab-Deruxtecan Administered for Metastatic Breast Cancers

NCT07195344 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT07195344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07195344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Patient's Morphological Characteristics on Pharmacokinetic and Toxicity of Trastuzumab-Deruxtecan Administered for Metastatic Breast Cancers
Lead sponsor
Institut Claudius Regaud
Phase
Phase 4
Overall status
Recruiting
Start date
October 15, 2025
Completion date
October 31, 2029
Enrollment
210 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced or metastatic breast cancers